• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy.

作者信息

Rhoades Ruben, Leong Ron, Kopenitz Jason, Thoma Brandi, McDermott Lydia, Dovidio Joseph, Barletti Shannon, Gong Jerald Z, Massey Howard T, McKenzie Steven E, Rame J Eduardo, Al-Rawas Nawar

机构信息

Division of Hematology, Department of Medicine, Thomas Jefferson University, Philadelphia, PA, United States of America.

Critical Care Division, Department of Anesthesia, Thomas Jefferson University, Philadelphia, PA, United States of America.

出版信息

Thromb Res. 2021 Jul;203:1-4. doi: 10.1016/j.thromres.2021.04.008. Epub 2021 Apr 19.

DOI:10.1016/j.thromres.2021.04.008
PMID:33894473
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8053597/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4104/8053597/b5ec1a955735/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4104/8053597/b5ec1a955735/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4104/8053597/b5ec1a955735/gr1_lrg.jpg

相似文献

1
Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy.体外膜肺氧合（ECMO）支持的COVID-19患者的凝血功能监测与抗凝管理：基于肝素抗Xa因子滴定策略的优势
Thromb Res. 2021 Jul;203:1-4. doi: 10.1016/j.thromres.2021.04.008. Epub 2021 Apr 19.
2
Anti-factor Xa vs aPTT for heparin monitoring in extracorporeal membrane oxygenation.抗因子 Xa 与 aPTT 在体外膜肺氧合中监测肝素的比较。
Am J Health Syst Pharm. 2023 May 24;80(Suppl 2):S77-S83. doi: 10.1093/ajhp/zxac351.
3
Evaluation of Anti-Xa and Activated Partial Thromboplastin Time Monitoring of Heparin in Adult Patients Receiving Extracorporeal Membrane Oxygenation Support.评估成人患者接受体外膜肺氧合支持时肝素的抗 Xa 和活化部分凝血活酶时间监测。
ASAIO J. 2020 Mar;66(3):300-306. doi: 10.1097/MAT.0000000000001004.
4
Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series.COVID-19 患者体外膜肺氧合治疗期间并发神经破坏性脑实质内出血：病例系列研究。
Neurosurgery. 2020 Aug 1;87(2):E147-E151. doi: 10.1093/neuros/nyaa198.
5
Activated Clotting Times Demonstrate Weak Correlation With Heparin Dosing in Adult Extracorporeal Membrane Oxygenation.活化凝血时间与成人体外膜肺氧合肝素剂量相关性弱。
Am J Ther. 2022 Jul 1;29(4):e385-e393. doi: 10.1097/MJT.0000000000001113.
6
Performance Assessment of a Multifaceted Unfractionated Heparin Dosing Protocol in Adult Patients on Extracorporeal Membrane Oxygenator.在体外膜肺氧合患者中使用多方面未分级肝素给药方案的性能评估。
Ann Pharmacother. 2021 May;55(5):592-604. doi: 10.1177/1060028020960409. Epub 2020 Sep 22.
7
The Impact and Statistical Analysis of a Multifaceted Anticoagulation Strategy in Children Supported on ECMO: Performance and Pitfalls.体外膜肺氧合（ECMO）支持下儿童多方面抗凝策略的影响及统计分析：效果与问题
J Intensive Care Med. 2017 Jan;32(1):59-67. doi: 10.1177/0885066615601977. Epub 2015 Aug 28.
8
Efficacy of thromboelastography in the management of anticoagulation for veno-venous extracorporeal membrane oxygenation in a coronavirus disease 2019 patient: A case report.血栓弹力描记术在管理 COVID-19 患者静脉-静脉体外膜肺氧合抗凝中的疗效：一例报告。
Medicine (Baltimore). 2021 Jun 11;100(23):e26313. doi: 10.1097/MD.0000000000026313.
9
Evaluation of a pharmacy managed heparin protocol for extracorporeal membrane oxygenation patients.评估用于体外膜肺氧合患者的药房管理肝素方案。
Perfusion. 2017 Apr;32(3):238-244. doi: 10.1177/0267659116678057. Epub 2016 Nov 11.
10
Efficacy of Bivalirudin for Therapeutic Anticoagulation in COVID-19 Patients Requiring ECMO Support.比伐芦定在需要 ECMO 支持的 COVID-19 患者中的治疗性抗凝效果。
J Cardiothorac Vasc Anesth. 2022 Feb;36(2):414-418. doi: 10.1053/j.jvca.2021.10.026. Epub 2021 Oct 20.

引用本文的文献

1
Acute Kidney Injury, Renal Replacement Therapy, and Extracorporeal Membrane Oxygenation Treatment During the COVID-19 Pandemic: Single-Center Experience.2019年冠状病毒病大流行期间的急性肾损伤、肾脏替代治疗和体外膜肺氧合治疗：单中心经验
Medicina (Kaunas). 2025 Jan 28;61(2):237. doi: 10.3390/medicina61020237.
2
Reduced anticoagulation strategy is associated with a lower incidence of intracerebral hemorrhage in COVID-19 patients on extracorporeal membrane oxygenation.在接受体外膜肺氧合治疗的新冠肺炎患者中，降低抗凝策略与脑出血发生率较低相关。
Intensive Care Med Exp. 2023 Jun 12;11(1):38. doi: 10.1186/s40635-023-00525-3.
3
Haematological Trends and Transfusion during Adult Extracorporeal Membrane Oxygenation: A Single Centre Study.
成人体外膜肺氧合期间的血液学趋势与输血：一项单中心研究
J Clin Med. 2023 Mar 31;12(7):2629. doi: 10.3390/jcm12072629.
4
Evolving outcomes of extracorporeal membrane oxygenation during the first 2 years of the COVID-19 pandemic: a systematic review and meta-analysis.COVID-19 大流行的头 2 年中体外膜肺氧合的治疗结局变化：系统回顾和荟萃分析。
Crit Care. 2022 May 23;26(1):147. doi: 10.1186/s13054-022-04011-2.
5
Complications of Critical COVID-19: Diagnostic and Therapeutic Considerations for the Mechanically Ventilated Patient.危重症 COVID-19 的并发症：机械通气患者的诊断和治疗注意事项。
Chest. 2022 Apr;161(4):989-998. doi: 10.1016/j.chest.2021.10.011. Epub 2021 Oct 13.